Literature DB >> 2147499

[Diagnosis of cerebral toxoplasmosis in AIDS patients. Value of antibodies evaluation in cerebrospinal fluid].

M E Bougnoux1, P Nicaise, F Heyer, T Ancelle, J L Pinquier, J Dupouy-Camet, C Tourte-Schaeffer.   

Abstract

The purpose of this study was to evaluate the diagnostic value of search for intrathecally synthesized specific antibodies in cerebral toxoplasmosis. Intrathecal synthesis of antibodies was measured by calculating the immunity load coefficient (ILC) in both serum and cerebrospinal fluid. In this retrospective study the records of 42 AIDS patients with clinically on the basis of computerized tomography and therapeutic results, and was excluded in 31 patients (control group). Specific immunoglobulins G were found in the cerebrospinal fluid of 9 out of the 11 patients with toxoplasmosis, but also in 14 of the 31 controls. Since ILC measurements in serum and cerebrospinal fluid identified 7/11 cases other hand, since the ILC value was higher than the positivity threshold in controls, the specificity of the test was assessed at 68 percent.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2147499

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  3 in total

1.  Detection of Toxoplasma gondii in AIDS patients by the polymerase chain reaction.

Authors:  N Cristina; H Pelloux; C Goulhot; J P Brion; P Leclercq; P Ambroise-Thomas
Journal:  Infection       Date:  1993 May-Jun       Impact factor: 3.553

2.  Detection of Toxoplasma gondii in venous blood from AIDS patients by polymerase chain reaction.

Authors:  J Dupouy-Camet; S L de Souza; C Maslo; A Paugam; A G Saimot; R Benarous; C Tourte-Schaefer; F Derouin
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

3.  Detection of Toxoplasma gondii by PCR and tissue culture in cerebrospinal fluid and blood of human immunodeficiency virus-seropositive patients.

Authors:  M Dupon; J Cazenave; J L Pellegrin; J M Ragnaud; A Cheyrou; I Fischer; B Leng; J Y Lacut
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.